{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:10:54Z","timestamp":1770271854942,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,27]]},"DOI":"10.7759\/cureus.74570","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:03:31Z","timestamp":1732705411000},"source":"Crossref","is-referenced-by-count":2,"title":["Rationale for the Use of Topical Calcineurin Inhibitors in the Management of Oral Lichen Planus and Mucosal Inflammatory Diseases"],"prefix":"10.7759","author":[{"given":"Michael B","family":"Chancellor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16464","article-title":"European S1 guidelines on the management of lichen planus: a cooperation of the European dermatology forum with the European Academy of Dermatology and Venereology","volume":"34","author":"Ioannides D","year":"2020","unstructured":"Ioannides D, Vakirlis E, Kemeny L, et al.. European S1 guidelines on the management of lichen planus: a cooperation of the European dermatology forum with the European Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol. 2020, 34:1403-14. 10.1111\/jdv.16464","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13810","article-title":"Malignant transformation of oral leukoplakia: systematic review and meta-analysis of the last 5 years","volume":"27","author":"Aguirre-Urizar JM","year":"2021","unstructured":"Aguirre-Urizar JM, Lafuente-Ib\u00e1\u00f1ez de Mendoza I, Warnakulasuriya S. Malignant transformation of oral leukoplakia: systematic review and meta-analysis of the last 5 years. Oral Dis. 2021, 27:1881-95. 10.1111\/odi.13810","journal-title":"Oral Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-016-1667-2","article-title":"Oral lichen planus: a literature review and update","volume":"308","author":"Alrashdan MS","year":"2016","unstructured":"Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res. 2016, 308:539-51. 10.1007\/s00403-016-1667-2","journal-title":"Arch Dermatol Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200309","article-title":"Oral lichen planus","volume":"192","author":"Hamour AF","year":"2020","unstructured":"Hamour AF, Klieb H, Eskander A. Oral lichen planus. CMAJ. 2020, 192:E892. 10.1503\/cmaj.200309","journal-title":"CMAJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001168.pub2","article-title":"Interventions for treating oral lichen planus","author":"Thongprasom K","year":"2011","unstructured":"Thongprasom K, Carrozzo M, Furness S, Lodi G. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2011, CD001168. 10.1002\/14651858.CD001168.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001168.pub3","article-title":"Interventions for treating oral lichen planus: corticosteroid therapies","volume":"2","author":"Lodi G","year":"2020","unstructured":"Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M. Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev. 2020, 2:CD001168. 10.1002\/14651858.CD001168.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","article-title":"The malignant transformation of oral lichen planus and -oral lichenoid lesion: a systematic review","volume":"145","author":"Fitzpatrick SG","year":"2014","unstructured":"Fitzpatrick SG, Hirsh SA, Gordon SC. The malignant transformation of oral lichen planus and -oral lichenoid lesion: a systematic review. JADA. 2014, 145:45-56.","journal-title":"JADA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12885","article-title":"Rate of malignant transformation of oral lichen planus: a systematic review","volume":"25","author":"Giuliani M","year":"2019","unstructured":"Giuliani M, Troiano G, Cordaro M, et al.. Rate of malignant transformation of oral lichen planus: a systematic review. Oral Dis. 2019, 25:693-709. 10.1111\/odi.12885","journal-title":"Oral Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2016.05.015","article-title":"AAOM clinical practice statement: oral licen planus and oral cancer","author":"Greenberg MS","year":"2015","unstructured":"Greenberg MS. AAOM clinical practice statement: oral licen planus and oral cancer. Oral Med. 2015, 122-2015. 10.1016\/j.oooo.2016.05.015","journal-title":"Oral Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00491.x","article-title":"Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders","volume":"36","author":"Hsue SS","year":"2007","unstructured":"Hsue SS, Wang WC, Chen CH, et al.. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders. J Oral Pathol Med. 2007, 36:25-9. 10.1111\/j.1600-0714.2006.00491.x","journal-title":"J Oral Pathol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s1368-8375(03)00134-9","article-title":"Cancer and oral lichen planus in a Swedish population","volume":"40","author":"Rodstrom PO","year":"2004","unstructured":"Rodstrom PO, Jontell M, Mattson U, Holmberg E. Cancer and oral lichen planus in a Swedish population. Oral Oncol. 2004, 40:131-8. 10.1016\/s1368-8375(03)00134-9","journal-title":"Oral Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.17778","article-title":"A retrospective clinicopathologic study on oral lichen planus and malignant transformation: analysis of 518 cases","volume":"17","author":"Shen ZY","year":"2012","unstructured":"Shen ZY, Liu W, Zhu LK, et al.. A retrospective clinicopathologic study on oral lichen planus and malignant transformation: analysis of 518 cases. Med Oral Patol Oral Cir Bucal. 2012, 17:943-7. 10.4317\/medoral.17778","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2011.05.029","article-title":"Squamous cell carcinoma development in previously diagnosed oral lichen planus: de novo or transformation?","volume":"112","author":"Shen ZY","year":"2011","unstructured":"Shen ZY, Liu W, Feng JQ, Zhou HW, Zhou ZT. Squamous cell carcinoma development in previously diagnosed oral lichen planus: de novo or transformation?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011, 112:592-6. 10.1016\/j.tripleo.2011.05.029","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2011.04.009","article-title":"Oral lichen planus and malignant transformation: a longitudinal cohort study","volume":"112","author":"Bombeccari GP","year":"2011","unstructured":"Bombeccari GP, Guzzi G, Tettamenti M, et al.. Oral lichen planus and malignant transformation: a longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011, 112:328-34. 10.1016\/j.tripleo.2011.04.009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12082763","article-title":"Comparative efficacy and safety of interventions for the treatment of oral lichen planus: a systematic review and network meta-analysis","volume":"12","author":"Leong XY","year":"2023","unstructured":"Leong XY, Gopinath D, Syeed SM, Veettil SK, Shetty NY, Menon RK. Comparative efficacy and safety of interventions for the treatment of oral lichen planus: a systematic review and network meta-analysis. J Clin Med. 2023, 12:10.3390\/jcm12082763","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2018.19.5.1161","article-title":"Oral lichen planus: An overview of potential risk factors, biomarkers and treatments","volume":"19","author":"Nosratzehi T","year":"2018","unstructured":"Nosratzehi T. Oral lichen planus: An overview of potential risk factors, biomarkers and treatments. Asian Pac J Cancer Prev. 2018, 19:1161-7. 10.22034\/APJCP.2018.19.5.1161","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2005.01165.x","article-title":"Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone","volume":"12","author":"Rhodus NL","year":"2006","unstructured":"Rhodus NL, Cheng B, Bowles W, Myers S, Miller L, Ondrey F. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. Oral Dis. 2006, 12:112-16. 10.1111\/j.1601-0825.2005.01165.x","journal-title":"Oral Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.10.1335","article-title":"Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study","volume":"138","author":"Olivier V","year":"2002","unstructured":"Olivier V, Lacour JP, Mousnier A, Garraffo R, Monteil RA, Ortonne JP. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol. 2002, 138:1335-8. 10.1001\/archderm.138.10.1335","journal-title":"Arch Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jop.13217","article-title":"Efficacy and safety of topical administration of tacrolimus in oral lichen planus: an updated systematic review and meta-analysis of randomized controlled trials","volume":"51","author":"Su Z","year":"2022","unstructured":"Su Z, Hu J, Cheng B, Tao X. Efficacy and safety of topical administration of tacrolimus in oral lichen planus: an updated systematic review and meta-analysis of randomized controlled trials. J Oral Pathol Med. 2022, 51:63-73. 10.1111\/jop.13217","journal-title":"J Oral Pathol Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18457","article-title":"Outcome and long-term treatment protocol for topical tacrolimus in oral lichen planus","volume":"36","author":"Utz S","year":"2022","unstructured":"Utz S, Suter VG, Cazzaniga S, Borradori L, Feldmeyer L. Outcome and long-term treatment protocol for topical tacrolimus in oral lichen planus. J Eur Acad Dermatol Venereol. 2022, 36:2459-65. 10.1111\/jdv.18457","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/eos.12761","article-title":"Corticosteroid delivery using oral mucosa equivalents for the treatment of inflammatory mucosal diseases","volume":"129","author":"Said Z","year":"2021","unstructured":"Said Z, Murdoch C, Hansen J, Siim Madsen L, Colley HE. Corticosteroid delivery using oral mucosa equivalents for the treatment of inflammatory mucosal diseases. Eur J Oral Sci. 2021, 129:e12761. 10.1111\/eos.12761","journal-title":"Eur J Oral Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.12.1508","article-title":"Response of oral lichen planus to topical tacrolimus in 37 patients","volume":"140","author":"Byrd JA","year":"2004","unstructured":"Byrd JA, Davis MD, Bruce AJ, Drage LA, Rogers RS 3rd. Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol. 2004, 140:1508-12. 10.1001\/archderm.140.12.1508","journal-title":"Arch Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12925","article-title":"Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis","volume":"54","author":"Chamani G","year":"2015","unstructured":"Chamani G, Rad M, Zarei MR, Lotfi S, Sadeghi M, Ahmadi Z. Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis. Int J Dermatol. 2015, 54:996-1004. 10.1111\/ijd.12925","journal-title":"Int J Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13790","article-title":"Efficacy of topical administration for oral lichen planus: a network meta-analysis","volume":"28","author":"Yuan P","year":"2022","unstructured":"Yuan P, Qiu X, Ye L, et al.. Efficacy of topical administration for oral lichen planus: a network meta-analysis. Oral Dis. 2022, 28:670-81. 10.1111\/odi.13790","journal-title":"Oral Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-022-02168-4","article-title":"Oral lichen planus: comparative efficacy and treatment costs - a systematic review","volume":"22","author":"Sandhu S","year":"2022","unstructured":"Sandhu S, Klein BA, Al-Hadlaq M, et al.. Oral lichen planus: comparative efficacy and treatment costs - a systematic review. BMC Oral Health. 2022, 22:161. 10.1186\/s12903-022-02168-4","journal-title":"BMC Oral Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.19080\/ADOH.2017.03.555611","article-title":"Fluocinolone acetonide 0.01% and dexamethasone 0.1% mouthwash in the treatment of symptomatic oral lichen planus","volume":"3","author":"Vathanasanti A","year":"2017","unstructured":"Vathanasanti A, Patnarin Kanjanabuch P. Fluocinolone acetonide 0.01% and dexamethasone 0.1% mouthwash in the treatment of symptomatic oral lichen planus. Adv Dent Oral Health. 2017, 3:3. 10.19080\/ADOH.2017.03.555611","journal-title":"Adv Dent Oral Health"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2020.02.014","article-title":"Dexamethasone solution and dexamethasone in Mucolox for the treatment of oral lichen planus: a preliminary study","volume":"129","author":"Villa A","year":"2020","unstructured":"Villa A, Sankar V, Bassani G, Johnson LB, Sroussi H. Dexamethasone solution and dexamethasone in Mucolox for the treatment of oral lichen planus: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020, 129:585-90. 10.1016\/j.oooo.2020.02.014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/16715.7225","article-title":"Medical management of oral lichen planus: a systematic review","volume":"10","author":"Suresh SS","year":"2016","unstructured":"Suresh SS, Chokshi K, Desai S, Malu R, Chokshi A. Medical management of oral lichen planus: a systematic review. J Clin Diagn Res. 2016, 10:10-15. 10.7860\/JCDR\/2016\/16715.7225","journal-title":"J Clin Diagn Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jop.13270. Epub 2022 Jan 13.","article-title":"Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: a phase 2 randomized clinical trial","volume":"51","author":"Brennan MT","year":"2022","unstructured":"Brennan MT, Madsen LS, Saunders DP, et al.. Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: a phase 2 randomized clinical trial. J Oral Pathol Med. 2022, 51:86-97. 10.1111\/jop.13270. Epub 2022 Jan 13.","journal-title":"J Oral Pathol Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(01)01994-7","article-title":"506-mediated T-cell apoptosis induction","volume":"33","author":"Migita K","year":"2001","unstructured":"Migita K, Eguchi K. 506-mediated T-cell apoptosis induction. Transpl Proc. 2001, 33:2292-3. 10.1016\/s0041-1345(01)01994-7","journal-title":"Transpl Proc"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1111\/cei.12604","article-title":"Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells","volume":"180","author":"De Bruyne R","year":"2015","unstructured":"De Bruyne R, Bogaert D, De Ruyck N, et al.. Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells. Clin Exp Immunol. 2015, 180:542-50.","journal-title":"Clin Exp Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.03.083","article-title":"Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity?","volume":"36","author":"Martins L","year":"2004","unstructured":"Martins L, Ventura A, Branco A, et al.. Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity?. Transpl Proc. 2004, 36:877-9. 10.1016\/j.transproceed.2004.03.083","journal-title":"Transpl Proc"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.10.123","article-title":"Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure","volume":"189","author":"Nirmal J","year":"2013","unstructured":"Nirmal J, Tyagi P, Chancellor MB, et al.. Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure. J Urol. 2013, 189:1553-8. 10.1016\/j.juro.2012.10.123","journal-title":"J Urol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.03.013","article-title":"Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study","volume":"54","author":"Ebert AK","year":"2008","unstructured":"Ebert AK, R\u00f6sch WH, Vogt T. Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol. 2008, 54:932-7. 10.1016\/j.eururo.2008.03.013","journal-title":"Eur Urol"},{"key":"ref35","unstructured":"A multicenter, dose-ranging trial evaluating the safety, tolerability, and efficacy of LP-10 in subjects with symptomatic oral lichen planus. (2024). https.\/\/clinicaltrials.gov\/study\/NCT06233591."},{"key":"ref36","article-title":"Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study","volume":"56","author":"Hafron J","year":"2024","unstructured":"Hafron J, Breyer BN, Joshi S, Smith C, Kaufman MR, Okonski J, Chancellor MB. Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study. Int Urol Nephrol. 2024, 56:87-96.","journal-title":"Int Urol Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/321023-rationale-for-the-use-of-topical-calcineurin-inhibitors-in-the-management-of-oral-lichen-planus-and-mucosal-inflammatory-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:03:36Z","timestamp":1732705416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/321023-rationale-for-the-use-of-topical-calcineurin-inhibitors-in-the-management-of-oral-lichen-planus-and-mucosal-inflammatory-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.74570","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}